Natixis Advisors LLC Purchases 53,352 Shares of Cabot Corporation $CBT

Natixis Advisors LLC raised its position in shares of Cabot Corporation (NYSE:CBTFree Report) by 36.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 201,034 shares of the specialty chemicals company’s stock after purchasing an additional 53,352 shares during the quarter. Natixis Advisors LLC owned 0.38% of Cabot worth $15,289,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CBT. Smartleaf Asset Management LLC boosted its holdings in shares of Cabot by 598.0% in the third quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock worth $27,000 after buying an additional 299 shares during the last quarter. Elevation Point Wealth Partners LLC purchased a new stake in Cabot during the second quarter valued at approximately $28,000. Parkside Financial Bank & Trust increased its holdings in Cabot by 95.5% during the second quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock valued at $29,000 after buying an additional 189 shares during the last quarter. Hantz Financial Services Inc. raised its position in Cabot by 227.5% in the third quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock worth $33,000 after acquiring an additional 298 shares during the period. Finally, Geneos Wealth Management Inc. raised its position in Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Analyst Upgrades and Downgrades

CBT has been the subject of a number of recent research reports. Jefferies Financial Group reissued a “buy” rating and set a $85.00 price objective on shares of Cabot in a research report on Wednesday, February 4th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cabot in a report on Monday, December 29th. Zacks Research upgraded Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. UBS Group boosted their price target on Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Finally, JPMorgan Chase & Co. reduced their price target on Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research report on Friday, November 28th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $73.75.

Read Our Latest Research Report on CBT

Cabot Stock Performance

Shares of NYSE CBT opened at $68.81 on Friday. The stock has a market cap of $3.59 billion, a PE ratio of 12.05, a price-to-earnings-growth ratio of 8.93 and a beta of 0.86. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $84.89. The firm has a fifty day moving average price of $73.08 and a 200-day moving average price of $71.17. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.09.

Cabot (NYSE:CBTGet Free Report) last released its earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.13. The company had revenue of $849.00 million for the quarter, compared to analysts’ expectations of $889.11 million. Cabot had a net margin of 8.62% and a return on equity of 22.82%. Cabot’s revenue for the quarter was down 11.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.76 EPS. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. Equities analysts anticipate that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Friday, February 27th will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Friday, February 27th. Cabot’s payout ratio is presently 31.52%.

Cabot Company Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Recommended Stories

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.